$NOTE
FiscalNote Holdings, Inc.

2021 Q3 Form 10-Q Financial Statement

#000110465921143280 Filed on November 24, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2021 Q2 2021 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $3.755M $2.989M
YoY Change
Gross Profit $15.57M $14.36M
YoY Change
Gross Profit Margin
Selling, General & Admin $1.071M $2.034M $250.4K
YoY Change
% of Gross Profit 13.06% 1.74%
Research & Development $6.433M $5.983M $5.255M
YoY Change
% of Gross Profit 38.42% 36.59%
Depreciation & Amortization $297.0K $3.792M $3.428M
YoY Change
% of Gross Profit 24.35% 23.87%
Operating Expenses $1.071M $2.034M $250.4K
YoY Change
Operating Profit -$1.071M -$2.034M -$250.4K
YoY Change 2947.53%
Interest Expense $3.563M $3.990M $3.705M
YoY Change
% of Operating Profit
Other Income/Expense, Net $2.250K $5.930K $45.52K
YoY Change
Pretax Income $2.494M $1.961M $3.500M
YoY Change
Income Tax -$992.0K -$2.556M -$3.189M
% Of Pretax Income -39.78% -130.31% -91.11%
Net Earnings $2.494M $1.961M $3.500M
YoY Change -7194.59%
Net Earnings / Revenue
Basic Earnings Per Share -$6.34
Diluted Earnings Per Share $114.0K $89.67K $160.0K
COMMON SHARES
Basic Shares Outstanding 16.72M
Diluted Shares Outstanding 16.72M

Balance Sheet

Concept 2021 Q3 2021 Q2 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $98.67K $23.53K $147.9K
YoY Change
Cash & Equivalents $98.67K $23.53K $147.9K
Short-Term Investments
Other Short-Term Assets $381.3K $535.5K $691.7K
YoY Change
Inventory
Prepaid Expenses $381.3K $535.5K
Receivables
Other Receivables
Total Short-Term Assets $480.0K $559.0K $839.6K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $175.1M $175.1M $175.1M
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $175.1M $175.1M $175.1M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $480.0K $559.0K $839.6K
Total Long-Term Assets $175.1M $175.1M $175.1M
Total Assets $175.6M $175.6M $175.9M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.607M $1.684M $99.97K
YoY Change
Accrued Expenses $1.387M $318.0K $148.2K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.994M $2.002M $248.2K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $15.67M $19.24M $23.23M
YoY Change
Total Long-Term Liabilities $15.67M $19.24M $23.23M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.994M $2.002M $248.2K
Total Long-Term Liabilities $15.67M $19.24M $23.23M
Total Liabilities $18.67M $21.24M $23.47M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$18.10M -$20.60M -$22.56M
YoY Change
Common Stock $256.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$18.10M -$20.60M -$22.56M
YoY Change
Total Liabilities & Shareholders Equity $175.6M $175.6M $175.9M
YoY Change

Cashflow Statement

Concept 2021 Q3 2021 Q2 2021 Q1
OPERATING ACTIVITIES
Net Income $2.494M $1.961M $3.500M
YoY Change -7194.59%
Depreciation, Depletion And Amortization $297.0K $3.792M $3.428M
YoY Change
Cash From Operating Activities $75.13K -$36.12K -$88.21K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures -$1.379M -$1.211M
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$21.56M -$3.643M
YoY Change
Cash From Investing Activities -$22.94M -$4.854M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -88.21K 236.1K
YoY Change
NET CHANGE
Cash From Operating Activities 75.13K -36.12K -88.21K
Cash From Investing Activities -22.94M -4.854M
Cash From Financing Activities 0.000 -88.21K 236.1K
Net Change In Cash 75.13K -124.3K 147.9K
YoY Change
FREE CASH FLOW
Cash From Operating Activities $75.13K -$36.12K -$88.21K
Capital Expenditures -$1.379M -$1.211M
Free Cash Flow $1.343M $1.123M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Repayments Of Debt
RepaymentsOfDebt
175626
CY2020Q3 us-gaap Repayments Of Debt
RepaymentsOfDebt
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
147860
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0001823466
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
00-0000000
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
dsac Threshold Business Days For Redemption Of Public Shares
ThresholdBusinessDaysForRedemptionOfPublicShares
P10D
CY2020Q4 us-gaap Deferred Income Noncurrent
DeferredIncomeNoncurrent
6125000
CY2021Q3 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
9547500
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-18102728
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39672
dei Entity Registrant Name
EntityRegistrantName
DUDDELL STREET ACQUISITION CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
dei Entity Address Address Line1
EntityAddressAddressLine1
8/F Printing House
dei Entity Address Address Line2
EntityAddressAddressLine2
6 Duddell Street
dei Entity Address Country
EntityAddressCountry
HK
dei City Area Code
CityAreaCode
852
dei Local Phone Number
LocalPhoneNumber
3468 6200
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
98665
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0
CY2021Q3 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
0
CY2020Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
411692
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
381322
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
789798
CY2021Q3 us-gaap Assets Current
AssetsCurrent
479987
CY2020Q4 us-gaap Assets Current
AssetsCurrent
1201490
CY2021Q3 us-gaap Assets Held In Trust
AssetsHeldInTrust
175084390
CY2020Q4 us-gaap Assets Held In Trust
AssetsHeldInTrust
175030689
CY2021Q3 us-gaap Assets
Assets
175564377
CY2020Q4 us-gaap Assets
Assets
176232179
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1607415
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4291
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1386753
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
179780
CY2021Q3 us-gaap Notes Payable Current
NotesPayableCurrent
0
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
175626
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2994168
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
359697
CY2021Q3 us-gaap Deferred Income Noncurrent
DeferredIncomeNoncurrent
6125000
CY2020Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
20805000
CY2021Q3 us-gaap Liabilities
Liabilities
18666668
CY2020Q4 us-gaap Liabilities
Liabilities
27289697
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1206973
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
0
CY2020Q3 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
0
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1071145
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3355975
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1603124
CY2020Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
34876
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-26057955
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-18102291
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-26057518
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
175564377
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
176232179
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
35148
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1071145
us-gaap Operating Income Loss
OperatingIncomeLoss
-3355975
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-35148
CY2021Q3 us-gaap Interest Income Other
InterestIncomeOther
2253
us-gaap Interest Income Other
InterestIncomeOther
53702
CY2020Q3 us-gaap Interest Income Other
InterestIncomeOther
0
CY2021Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3562500
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-11257500
CY2020Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
2493608
us-gaap Net Income Loss
NetIncomeLoss
7955227
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-35148
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-26057518
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
3500152
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-22557366
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
1961467
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-20595899
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
2493608
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-18102291
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
0
CY2020Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-35148
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-10148
us-gaap Net Income Loss
NetIncomeLoss
7955227
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-35148
us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
88206
CY2020Q3 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
272
us-gaap Investment Income Interest
InvestmentIncomeInterest
53702
CY2020Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
0
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-11257500
CY2020Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-408477
CY2020Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
0
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-49195
CY2020Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
323486
CY2020Q3 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
98665
dsac Offering Costs Included In Accrued Expenses
OfferingCostsIncludedInAccruedExpenses
0
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
98665
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0
dsac Prepaid Expenses Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares
PrepaidExpensesPaidBySponsorInExchangeForIssuanceOfClassBOrdinaryShares
0
CY2020Q3 dsac Prepaid Expenses Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares
PrepaidExpensesPaidBySponsorInExchangeForIssuanceOfClassBOrdinaryShares
25000
CY2020Q3 dsac Offering Costs Included In Accrued Expenses
OfferingCostsIncludedInAccruedExpenses
218352
us-gaap Stock Issued1
StockIssued1
0
CY2020Q3 us-gaap Stock Issued1
StockIssued1
86410
dsac Condition For Future Business Combination Number Of Businesses Minimum
ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum
1
CY2021Q3 us-gaap Share Price
SharePrice
10.00
dsac Minimum Percentage Of Trust Account Required For Business Combination
MinimumPercentageOfTrustAccountRequiredForBusinessCombination
0.80
CY2021Q3 dsac Redeem Shares
RedeemShares
10.00
CY2021Q3 us-gaap Assets Net
AssetsNet
5000001
CY2021Q3 us-gaap Restricted Investments Percent Of Net Assets
RestrictedInvestmentsPercentOfNetAssets
0.20
dsac Percentage Obligation To Redeem Public Shares If Entity Does Not Complete Business Combination
PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination
1
dsac Dissolution Expenses
DissolutionExpenses
100000
dsac Trust Account Description
TrustAccountDescription
In connection with the redemption of 100% of the Company’s outstanding Public Shares for a portion of the funds held in the Trust Account, each holder will receive a full pro rata portion of the amount then in the Trust Account, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay the Company’s taxes payable (less up to $100,000 of interest to pay dissolution expenses).
CY2021Q3 dsac Minimum Net Intangible Assets Upon Redemption Of Temporary Equity
MinimumNetIntangibleAssetsUponRedemptionOfTemporaryEquity
5000001
CY2021Q1 us-gaap Assets
Assets
175915799
CY2021Q1 us-gaap Liabilities
Liabilities
23473165
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-22557803
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-22557366
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
175915799
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-88206
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-236066
CY2021Q2 us-gaap Assets
Assets
175641121
CY2021Q2 us-gaap Liabilities
Liabilities
21237021
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-20596337
CY2021Q2 dsac Stockholders Equity1
StockholdersEquity1
-20595900
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
175641121
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
124326
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-147860
CY2021Q3 us-gaap Cash
Cash
99000
CY2021Q3 dsac Working Capital Deficit
WorkingCapitalDeficit
2500000
dsac Contribution Of From The Sponsor To Cover Certain Expenses
ContributionOfFromTheSponsorToCoverCertainExpenses
25000
dsac Loan Amount From Sponsor
LoanAmountFromSponsor
176000
us-gaap Affiliate Costs
AffiliateCosts
2000000.0
dsac Aggregate Expenses
AggregateExpenses
1600000
CY2021Q3 dsac Working Capital Loans
WorkingCapitalLoans
0
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The preparation of the unaudited condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p>
dsac Investments Maximum Maturity Term
InvestmentsMaximumMaturityTerm
P185D
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Concentration of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000, and investments held in the Trust Account. At September 30, 2021 and December 31, 2020, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</p>
CY2021Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2021Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2020Q4 dsac Deferred Underwriting Fees Payable Non Current
DeferredUnderwritingFeesPayableNonCurrent
6100000
CY2020Q4 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
17500000
CY2020Q3 dsac Sponsor Agreed Description
SponsorAgreedDescription
The Sponsor agreed to surrender for no consideration 656,250 founder shares when the option to purchase additional units was not exercised by the underwriters.
CY2021Q3 us-gaap Due From Affiliate Noncurrent
DueFromAffiliateNoncurrent
0
CY2020Q4 us-gaap Due From Affiliate Noncurrent
DueFromAffiliateNoncurrent
2000000.0
CY2021Q3 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
0
CY2020Q4 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
1600000
dsac Working Capital Loan Amount
WorkingCapitalLoanAmount
1500000
dsac Price Per Share Warrants
PricePerShareWarrants
1.00
CY2021Q3 dsac Maximum Number Of Demands For Registration Of Securities
MaximumNumberOfDemandsForRegistrationOfSecurities
3
dsac Underwriting Discount Per Unit
UnderwritingDiscountPerUnit
0.20
CY2021Q3 dsac Deferred Underwriting Fees Amount Payable
DeferredUnderwritingFeesAmountPayable
3500000
dsac Additional Unit Per Shares
AdditionalUnitPerShares
0.35
CY2021Q3 dsac Aggregate Deferred Underwriting Commission
AggregateDeferredUnderwritingCommission
6100000
dsac Maximum Thres Hold Period For Filing Registration Statement After Business Combination
MaximumThresHoldPeriodForFilingRegistrationStatementAfterBusinessCombination
P15D
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
dsac Threshold Conversion Ratio Of Stock
ThresholdConversionRatioOfStock
1
dsac Warrants And Rights Outstanding Exercisable Term From Closing Of Business Combination
WarrantsAndRightsOutstandingExercisableTermFromClosingOfBusinessCombination
P30D
dsac Warrants And Rights Outstanding Exercisable Term From Closing Of Initial Public Offering
WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering
P12M
CY2021Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
CY2021Q3 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
dsac Threshold Issue Price For Capital Raising Purposes In Connection With Closing Of Business Combination
ThresholdIssuePriceForCapitalRaisingPurposesInConnectionWithClosingOfBusinessCombination
9.20
dsac Percentage Of Gross Proceeds On Total Equity Proceeds
PercentageOfGrossProceedsOnTotalEquityProceeds
0.60
dsac Threshold Trading Days For Calculating Market Value
ThresholdTradingDaysForCalculatingMarketValue
20
dsac Threshold Issue Price For Capital Raising Purposes In Connection With Closing Of Business Combination
ThresholdIssuePriceForCapitalRaisingPurposesInConnectionWithClosingOfBusinessCombination
9.20
dsac Class Of Warrant Or Right Adjustment Of Exercise Price Of Warrants Or Rights Percent Based On Market Value And Newly Issued Price
ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice
1.15
dsac Class Of Warrant Or Right Adjustment Of Redemption Price Of Warrants Or Rights Percent Based On Market Value And Newly Issued Price1
ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1
1
dsac Class Of Warrant Or Right Adjustment Of Redemption Price Of Warrants Or Rights Percent Based On Market Value And Newly Issued Price2
ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice2
1.80
dsac Common Stock Trading Days On Which Fair Market Value Of Shares Is Reported
CommonStockTradingDaysOnWhichFairMarketValueOfSharesIsReported
10
dsac Multiplier Used In Calculating Warrant Exercise Price
MultiplierUsedInCalculatingWarrantExercisePrice
0.361
CY2021Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
175084390
CY2020Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
175030689

Files In Submission

Name View Source Status
0001104659-21-143280-index-headers.html Edgar Link pending
0001104659-21-143280-index.html Edgar Link pending
0001104659-21-143280.txt Edgar Link pending
0001104659-21-143280-xbrl.zip Edgar Link pending
dsac-20210930.xsd Edgar Link pending
dsac-20210930x10q.htm Edgar Link pending
dsac-20210930x10q_htm.xml Edgar Link completed
dsac-20210930xex31d1.htm Edgar Link pending
dsac-20210930xex31d2.htm Edgar Link pending
dsac-20210930xex32d1.htm Edgar Link pending
dsac-20210930xex32d2.htm Edgar Link pending
dsac-20210930_cal.xml Edgar Link unprocessable
dsac-20210930_def.xml Edgar Link unprocessable
dsac-20210930_lab.xml Edgar Link unprocessable
dsac-20210930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending